Daphni | Blue Fund

vc$282MCo-investsLeads rounds

◆ Fund Size

$282M

◆ Check Size

$0.3M→$3.0M

◆ Location

France

◆ Portfolio

80 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Dedicated vehicle for companies built on scientific and engineering breakthroughs, focusing on European science across disciplines to build companies addressing major societal and environmental challenges.

◆ About Daphni

Daphni Blue is a €260 million venture fund by French VC firm Daphni that invests in early-stage European startups driven by scientific breakthroughs in fields like biology, physics, chemistry, mathematics, life sciences, deep tech, and sustainability.[1][2][3][4]

◆ Sectors

Advanced MaterialsBiotechDrug DiscoverySustainable MaterialsIndustrial Automation

◆ Stages

seed

◆ Geography Focus

Europe

◆ Team

Name	Title	Role	Links
Marc Simoncini	Venture Partner	—	in 𝕏
Marie Ekeland	Co-founder	—	in 𝕏
Mathieu Daix	Co-founder	—	in 𝕏
Pauline Boucher	Venture Partner	—	in
Pierre-Eric Leibovici	Co-founder & Managing Partner	—	in 𝕏
Pierre-Yves Meerschman	Co-founder Partner	—	in 𝕏
Willy Braun	Co-founder	—	in 𝕏

◆ Notable Investments

Ternary TherapeuticsRocapineGraph TherapeuticsAstral Systemswilgo.aiBack MarketSwileZOE

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Blue Fund invest in?

Blue Fund invests in Advanced Materials, Biotech, Drug Discovery, Sustainable Materials and Industrial Automation at the seed stage.

Which geographies does Blue Fund focus on?

Blue Fund focuses on Europe, and is headquartered in France.

What is Blue Fund's typical check size?

Blue Fund typically writes checks of $0.3M to $3M.